PCM
AGTC

Portolan Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Portolan Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,600,902
Closed -$435K – 166
2022
Q3 		$435K Sell
1,600,902
-4,697
-0.3% -$2.05K 0.05% 126
2022
Q2 		$1.24M Hold
1,605,599
– – 0.12% 120
2022
Q1 		$1.72M Buy
1,605,599
+244,895
+18% +$445K 0.14% 121
2021
Q4 		$2.58M Buy
1,360,704
+97,283
+8% +$233K 0.17% 107
2021
Q3 		$3.8M Sell
1,263,421
-132,946
-10% -$474K 0.28% 100
2021
Q2 		$5.46M Sell
1,396,367
-124,538
-8% -$516K 0.39% 90
2021
Q1 		$7.71M Buy
1,520,905
+213,178
+16% +$1.11M 0.61% 68
2020
Q4 		$5.35M Buy
1,307,727
+6,652
+0.5% +$32.7K 0.49% 77
2020
Q3 		$6.32M Buy
1,301,075
+515,088
+66% +$2.81M 0.72% 58
2020
Q2 		$4.35M Buy
785,987
+310,191
+65% +$1.42M 0.5% 76
2020
Q1 		$1.56M Buy
+475,796
New +$2.51M 0.23% 101

Portolan Capital Management's AGTC Position: Q4 2022 in Review

Portolan Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 1,600,902 shares — an estimated $435K sold.

Portolan Capital Management first reported a position in AGTC in Q1 2020 and held it in 11 quarters. The position peaked at $7.71M in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • Portolan Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • Portolan Capital Management sold 1,600,902 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $435K.
  • Portolan Capital Management first reported a position in Applied Genetic Technologies Corporation in Q1 2020 and held it in 11 quarters.
  • Portolan Capital Management's Applied Genetic Technologies Corporation position peaked at $7.71M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Portolan Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.